Skip to main content
    O

    Oculis Holding AG Ordinary shares (OCS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.63
    -0.01 (-0.13%)

    Market Cap: $425.67M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Oculis Holding AG Ordinary shares (OCS) Financials: Revenue, Profit and Cash Flow

    Updated Nov 3, 2026. Financial statements from company filings, amounts in CHF.

    Oculis Holding AG Ordinary shares reported revenue of CHF 0 for the fiscal year ended Dec 31, 2025, down 100.0% from the year before. That year, net income was CHF -94.51M, operating cash flow was CHF -62.22M and free cash flow was CHF -62.51M. The quarter ended Sep 30, 2026 had revenue of CHF 7.00K and net income of CHF -18.24M.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of CHF 79.15M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 20250-100.0%N/AN/AN/A
    Dec 2024686.00K-22.3%-7492.3%-10671.1%-12503.9%
    Dec 2023883.00K-3.2%-3212.2%-9140.9%-10056.9%
    Dec 2022912.00K-5.0%-2336.8%-3550.0%-4243.2%
    Dec 2021960.00K-3.3%-896.7%-1378.3%-1932.5%
    Dec 2020993.00KN/A-840.3%-1242.3%-1497.8%
    Annual, fiscal years ended Dec 2020 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Revenue0686.00K883.00K912.00K960.00K993.00K
    Cost of revenueN/A52.08M29.25M22.22M9.57M9.34M
    Gross profitN/A-51.40M-28.36M-21.31M-8.61M-8.34M
    Research and development54.52M52.08M29.25M22.22M9.57M9.34M
    Operating income-79.15M-73.20M-80.71M-32.38M-13.23M-12.34M
    Net income-94.51M-85.78M-88.80M-38.70M-18.55M-14.87M
    EBITDAN/AN/AN/A-31.90M-13.17M-12.10M
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue7.00K000243.00K261.00K000245.00K222.00K185.00K
    Gross profit7.00KN/A-157.43KN/A243.00K-14.65MN/AN/AN/A-16.22M-10.63M-7.84M
    Operating income-23.64M-23.57M-22.43M-20.88M-20.30M-20.77M-19.97M-17.26M-18.13M-22.48M-15.33M-12.18M
    Net income-18.24M-9.97M-29.50M-23.34M-16.86M-25.38M-33.21M-28.66M-20.19M-20.84M-16.09M-12.50M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of CHF 502.57K by 80.92M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Total assets236.23M120.35M114.35M37.06M58.04M16.38M
    Current assets219.14M104.90M101.02M23.66M47.98M6.16M
    Cash and equivalents81.42M27.71M38.33M19.79M46.28M4.95M
    Total liabilities39.94M46.97M20.63M135.05M119.00M60.04M
    Short-term debt502.57K315.00K174.00K142.00K193.00K188.00K
    Long-term debtN/AN/AN/A122.45M113.50M53.98M
    Shareholder equity196.29M73.38M93.73M-97.99M-60.95M-43.65M
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets232.32M250.34M243.26M236.23M167.84M181.62M204.17M120.35M125.61M138.73M98.71M114.35M
    Total liabilities23.57M31.00M47.20M39.94M37.24M38.52M41.55M46.97M30.38M25.91M19.68M20.63M
    Cash and equivalents66.29M8.00K64.37M81.42M46.44M64.27M59.87M27.71M35.63M43.85M24.36M38.33M
    Shareholder equity208.75M219.34M196.06M196.29M130.59M143.10M162.63M73.38M95.23M112.83M79.03M93.73M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Operating cash flow-62.22M-47.50M-53.84M-25.07M-13.82M-12.03M
    Capital expenditures287.47K230.00K48.00K3.55M28.00K19.00K
    Free cash flow-62.51M-47.73M-53.89M-28.62M-13.85M-12.05M
    Investing cash flow-59.38M-17.56M-54.21M-3.55M-28.00K-19.00K
    Financing cash flow178.60M54.03M129.67M1.71M55.19M4.86M
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-18.96M-20.23M-15.54M-16.68M-13.42M-17.24M-18.96M-10.36M-10.43M-13.52M-13.72M-13.02M
    Capital expendituresN/A14.00K7.16K38.00K124.00K126.00K1.10M57.00K154.00K19.00K35.00K
    Free cash flowN/A-20.25M-15.54M-16.72M-13.54M-17.37M-20.06M-10.41M-10.59M-13.53M-13.72M-13.02M
    Last 12 quarters

    Frequently Asked Questions About OCS

    What is Oculis Holding AG Ordinary shares' annual revenue?

    Oculis Holding AG Ordinary shares reported revenue of CHF 0 for the fiscal year ended Dec 31, 2025.

    How fast is Oculis Holding AG Ordinary shares' revenue growing?

    Revenue was down 100.0% for the fiscal year ended Dec 31, 2025 compared with the year before.

    Is Oculis Holding AG Ordinary shares profitable?

    No. Oculis Holding AG Ordinary shares reported net income of CHF -94.51M for the fiscal year ended Dec 31, 2025.

    How much free cash flow does OCS generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of CHF -62.22M minus capital expenditures of CHF 287.47K produced free cash flow of CHF -62.51M.

    How much debt does Oculis Holding AG Ordinary shares have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of CHF 502.57K and cash and equivalents of CHF 81.42M.